R Upton, A Banuelos, D Feng… - Proceedings of the …, 2021 - National Acad Sciences
Trastuzumab, a targeted anti-human epidermal-growth-factor receptor-2 (HER2) monoclonal
antibody, represents a mainstay in the treatment of HER2-positive (HER2+) breast cancer …